|
|
|
|
|
by mike_hearn
749 days ago
|
|
The "consumer" who "buys" research in a commercial setting is usually the executive who is funding the department. In that context stuff like P-hacking, HARKing etc doesn't happen much because at some point your bosses boss is going to read your internal paper and notice that your claimed discovery has nothing to do with what you were originally asked to investigate. In academia that doesn't matter, it still counts as a discovery because nobody is really checking your pre-registrations. In corporate research it'll either be checked by the people paying your salary, or at a larger scale, it'll be checked by a regulator who is forcing you to pre-register your clinical trials. |
|
As for commercial research, similar problems of fraud exist as in academic research. Instead of prestige, the motivations are things like bonuses and promotions.
Academics actually care a great deal about fraud, funding agencies hate fraud and punish it, journals hate fraud - everyone dislikes it. Competing labs have every incentive to catch fraud conducted by their rivals. The idea that academia is rife with fraud and that nobody cares is just not true.
There will always be a certain level of fraud not just in research, but in every economic sector, every intellectual pursuit, and every sport, commercial or not. There's no system that will perfectly eliminate it, but because of its empiricism and openness, science is fairly good at correcting itself over time.